VivoSim Labs, Inc. Total Liabilities
VivoSim Labs, Inc. (VIVS) had Total Liabilities of $6.19 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-12
- 2026-06-30: Liabilities $6.19M.
- 2026-03-31: Liabilities $8.48M.
- 2025-12-31: Liabilities $2.52M.
- 2025-09-30: Liabilities $2.62M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $6.19M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $8.48M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $2.52M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $2.62M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $2.44M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $4.16M 10-K · filed 2026-07-14 | |
| 2024-12-31 | $3.48M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $3.07M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $2.81M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $2.75M 10-K · filed 2025-06-05 | |
| 2023-12-31 | $2.70M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $2.71M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.98M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.98M 10-K · filed 2024-05-31 | |
| 2022-12-31 | $2.79M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $2.90M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.89M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.09M 10-K · filed 2023-07-14 | |
| 2021-12-31 | $3.80M 10-Q · filed 2022-02-14 | |
| 2021-03-31 | $721.00K 10-K · filed 2022-06-10 | |
| 2020-03-31 | $1.81M 10-K · filed 2020-05-28 | |
| 2019-12-31 | $2.36M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $6.70M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $7.31M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.33M 10-K · filed 2020-05-28 | |
| 2018-12-31 | $4.01M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $3.75M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.74M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $5.24M 10-K · filed 2019-06-03 | |
| 2017-12-31 | $4.95M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $4.85M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $4.44M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $6.82M 10-K · filed 2018-05-31 | |
| 2016-12-31 | $5.23M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $5.05M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $4.00M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $5.39M 10-K · filed 2017-06-07 | |
| 2015-12-31 | $5.50M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $5.53M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.24M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $4.79M 10-K · filed 2016-06-09 | |
| 2014-12-31 | $3.76M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $3.11M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $3.09M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $1.90M 10-K · filed 2015-06-09 | |
| 2013-12-31 | $2.91M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $2.96M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $7.60M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $8.41M 10-K · filed 2014-06-10 | |
| 2012-12-31 | $22.05M 10-K · filed 2014-06-10 | |
| 2012-09-30 | $34.47M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $81.47M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $48.63M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $3.24M 10-KT · filed 2013-05-24 | $74.02K 10-Q · filed 2012-01-17 |
| 2011-09-30 | $32.19K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $10.69K 10-Q · filed 2012-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |